

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">

<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infert</journal-id>
      <journal-id journal-id-type="publisher-id">arij001</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">jri50052</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Recurrent Miscarriage and Implantation Failure of Unknown Cause Studied by a Panel of Thrombophilia Conditions: Increased Frequency of FXIII Val34Leu Polymorphism</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Diaz-Nu&#241;ez</surname><given-names>Maria</given-names></name></contrib><aff>Human Reproduction Unit, Cruces University Hospital, Biocruces, Barakaldo, Spain</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Rabanal</surname><given-names>Aintzane</given-names></name></contrib><aff>Human Reproduction Unit, Cruces University Hospital, Biocruces, Barakaldo, Spain</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Exp&#243;sito</surname><given-names>Antonia</given-names></name></contrib><aff>Human Reproduction Unit, Cruces University Hospital, Biocruces, Barakaldo, Spain</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ferrando</surname><given-names>Marcos</given-names></name></contrib><aff>IVI Bilbao, Bizkaia, Spain</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Quintana</surname><given-names>Fernando</given-names></name></contrib><aff>IVI Bilbao, Bizkaia, Spain</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Soria</surname><given-names>Jose</given-names></name></contrib><aff>Unit of Genomics of Complex Diseases, Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Matorras</surname><given-names>Roberto</given-names></name></contrib><aff>Human Reproduction Unit, Cruces University Hospital, Biocruces, Barakaldo, Spain</aff><aff>IVI Bilbao, Bizkaia, Spain</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>20</volume>
      <issue>2</issue>
      <fpage>076</fpage>
      <lpage>83</lpage>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>12</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>3</month>
          <year>2019</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: The role of acquired thrombophilia has been accepted as an etiology of recurrent miscarriage (RM); however, the contribution of specific inherited thrombophilic genes to this disorder has remained controversial. An increased incidence of RM has been suggested in women with inherited thrombophilia.&amp;nbsp;&lt;br /&gt;
Methods: In this prospective study, assisted women with RM or repeated implant failure (RIF) were subjected to Thromboincode analysis, in order to identify 12 genetic variants for Factor V Leiden, Factor V Hong Kong, Factor V Cambridge, FII, FXIII, FXII, and A1 carriers. Patients included in this study were separated in RM cases (n=43), RIF cases (n=36) and RIF+RM (n=76). As a control group, patients undergoing IVF treatment (n=34) were used and a previously described 249 cases population as a representative sample of Spanish population were selected. Level of statistical significance was p&amp;lt;0.05 and groups were compared by Fisher test, except for age that was compared by t-test.&lt;br /&gt;
Results: Regarding FXIII, higher values were observed in RM (69.76%), RIF (70%) and in RM+RIF (68.42%) group when compared with our control group (52.94%) and general Spanish population (56.5%), but these differences were statistically significant only in RIF group (p=0.043, p=0.01).&lt;br /&gt;
Conclusion: Concerning our findings, both RM and RIF patients had a very similar panel of thrombophilia polymorphisms, suggesting that, in both, thrombophilia might have an important contribution. High frequency of Val34Leu polymorphism in RM/RIF presumably speaks in favor of a multifactorial RM genesis, wherean altered thrombophilia status plays a role.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>

    
</article>

